Doucet N - Search Results

1

Semi-rational evolution of the 3-(3-hydroxyalkanoyloxy)alkanoate (HAA) synthase RhlA to improve rhamnolipid production in Pseudomonas aeruginosa and Burkholderia glumae.

Dulcey CE, López de Los Santos Y, Létourneau M, Déziel E, Doucet N. Dulcey CE, et al. Among authors: doucet n. FEBS J. 2019 Oct;286(20):4036-4059. doi: 10.1111/febs.14954. Epub 2019 Jun 21. FEBS J. 2019. PMID: 31177633 Free PMC article.

2

Cardiotoxin-I: an unexpectedly potent insulinotropic agent.

Nguyen TT, Folch B, Létourneau M, Vaudry D, Truong NH, Doucet N, Chatenet D, Fournier A. Nguyen TT, et al. Among authors: doucet n. Chembiochem. 2012 Aug 13;13(12):1805-12. doi: 10.1002/cbic.201200081. Epub 2012 Jul 16. Chembiochem. 2012. PMID: 22807058

3

Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide.

Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D. Doan ND, et al. Among authors: doucet n. J Control Release. 2012 Oct 28;163(2):256-65. doi: 10.1016/j.jconrel.2012.08.021. Epub 2012 Aug 24. J Control Release. 2012. PMID: 22922050

4

Structural and functional importance of local and global conformational fluctuations in the RNase A superfamily.

Gagné D, Doucet N. Gagné D, et al. Among authors: doucet n. FEBS J. 2013 Nov;280(22):5596-607. doi: 10.1111/febs.12371. Epub 2013 Jun 24. FEBS J. 2013. PMID: 23763751 Free article. Review.

5

Systematic mutational analysis of the putative hydrolase PqsE: toward a deeper molecular understanding of virulence acquisition in Pseudomonas aeruginosa.

Folch B, Déziel E, Doucet N. Folch B, et al. Among authors: doucet n. PLoS One. 2013 Sep 10;8(9):e73727. doi: 10.1371/journal.pone.0073727. eCollection 2013. PLoS One. 2013. PMID: 24040042 Free PMC article.

6

The end of an old hypothesis: the pseudomonas signaling molecules 4-hydroxy-2-alkylquinolines derive from fatty acids, not 3-ketofatty acids.

Dulcey CE, Dekimpe V, Fauvelle DA, Milot S, Groleau MC, Doucet N, Rahme LG, Lépine F, Déziel E. Dulcey CE, et al. Among authors: doucet n. Chem Biol. 2013 Dec 19;20(12):1481-91. doi: 10.1016/j.chembiol.2013.09.021. Epub 2013 Nov 14. Chem Biol. 2013. PMID: 24239007 Free PMC article.

7

Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.

Chatenet D, Folch B, Feytens D, Létourneau M, Tourwé D, Doucet N, Fournier A. Chatenet D, et al. Among authors: doucet n. J Med Chem. 2013 Dec 12;56(23):9612-22. doi: 10.1021/jm401153j. Epub 2013 Nov 26. J Med Chem. 2013. PMID: 24251366

8

Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity.

Nguyen TT, Folch B, Létourneau M, Truong NH, Doucet N, Fournier A, Chatenet D. Nguyen TT, et al. Among authors: doucet n. J Med Chem. 2014 Mar 27;57(6):2623-33. doi: 10.1021/jm401904q. Epub 2014 Mar 4. J Med Chem. 2014. PMID: 24552570

9

Photoreleasable ligands to study intracrine angiotensin II signalling.

Tadevosyan A, Létourneau M, Folch B, Doucet N, Villeneuve LR, Mamarbachi AM, Pétrin D, Hébert TE, Fournier A, Chatenet D, Allen BG, Nattel S. Tadevosyan A, et al. Among authors: doucet n. J Physiol. 2015 Feb 1;593(3):521-39. doi: 10.1113/jphysiol.2014.279109. Epub 2015 Jan 7. J Physiol. 2015. PMID: 25433071 Free PMC article.

10

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Vladoiu MC, Labrie M, Létourneau M, Egesborg P, Gagné D, Billard É, Grosset AA, Doucet N, Chatenet D, St-Pierre Y. Vladoiu MC, et al. Among authors: doucet n. Oncotarget. 2015 Dec 1;6(38):40970-80. doi: 10.18632/oncotarget.5403. Oncotarget. 2015. PMID: 26543238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters